medigraphic.com

2007, Número S1

<< Anterior Siguiente >>

Arch Cardiol Mex 2007; 77 (S1)


1. Definición, fisiopatología y clasificación

Guadalajara BJF, Quiroz MVA, Martínez-Reding GJO

Idioma: Español
Referencias bibliográficas: 53
Paginas: 18-26
Archivo PDF: 140.31 Kb.


FRAGMENTO

Definiciones de insuficiencia cardíaca

Función del corazón
El corazón es una bomba muscular que al generar presión desplaza un volumen líquido cuya función es la de abastecer de sangre oxigenada a los tejidos del organismo y recobrar la sangre insaturada y enviarla a oxigenarse a los pulmones para mantener la vida.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Ross J. Jr: Cardiac Function and Myocardial Contractility. A Perspective. J. Am Coll Cardiol 1983; 1: 52-59.

  2. Ford L: Mechanical Manifestations of Activation in Cardiac Muscle. Circ Res 1991; 68: 621-625.

  3. Brutsaert DL, Sonnenblick EH: Cardiac Muscle Mechanics in the Evaluation of Myocardial Contractility and Pump Function: Problems, Concepts and Directions. Prog Cardiovasc Dis 1973; 16: 337-348.

  4. Braunwald E, Ross J Jr: Control of Cardiac Performance. En: Berne R.M. ED Handbook of Physiology. Am Society of Physiology vol. 1, 1979; Pag. 533-580.

  5. Hirota Y, Shimisu G, Kawamura K: Assessment of Cardiac Function in Diseased Heart by Catheterization Study. En Hori, Suga, Baan, Yellin Eds. «Cardiac Mechanics and Function is Normal and Diseased Heart. Springer-Verlag. Tokio 1989; Pags. 283-290.

  6. Frohlich ED, Aptein C, Chobanian, et al: The Heart in Hypertension. N Engl J Med 1992; 320: 998-1007.

  7. Weber KT, Janiky JS: Myocardial Oxygen Consumption, the Role of Wall Force and Shortening. Am J Physiol 1977; 233(4): H421-H430.

  8. Sonnenblick EH, Ross J Jr., Braunwald E: Oxygen Consumption of the Heart. Am J Cardiol 1986; 22: 328-334.

  9. Weber KT, Janicky JS: The Heart as a Muscle-Pump System and the Concept of Heart Failure. Am Heart J 1979; 98: 371-384.

  10. Mason DT: Congestive Heart Failure, Mechanism, Evaluation and Treatment. York Med. Books, New York 1976. Pag. 1.

  11. Brandt RR, Wright S, Red field MM: Atrial Natriuretic Peptide in Heart Failure. J Am Coll Cardiol 1993; 22 (suppl. A): 86A-92A.

  12. Mahler F, Yoran C, Ross Jr. J: Inotropic Effect of Tachycardia and Post-stimulation in the Consciencius Dog. Am J Physiol 1974; 227: 569-575.

  13. Dzau VJ, Colucci WS, Hollemberg NK, William GH: Relation of the Renin-Angiotensin-Aldosterone System to Clinical State in Congestive Heart Failure. Circulation 1981; 63: 645-651.

  14. Gaasch WH: Left Ventricular Radius to Wall Thickness Ratio. Am J Cardiol 1979; 43: 1189-1194.

  15. Grossman W: Cardiac Hypertrophy: Useful Adaptation or Pathologic Process. Am J Med 1980; 69: 576-584.

  16. Thiedemann KU, Holeibarsch C, Mediegorac I, Jacob R: Connective Tissue Content and Myocardial Stiffness in Pressure Overload Hypertrophy: A combined Study of Morphologic, Morphometric, Biochemical and Mechanical Parameters. Basic Res Cardiol 1983; 78: 140-155.

  17. Hanrath P, Mathey DG, Siegent R, Bleifield W: Left Ventricular Relaxation and Filling Pattern in Diferent Forms of Left Ventricular Hypertrophy: An Echocardiographic Study. Am J Cardiol 1980; 45: 15-23.

  18. Strauer BE: Hypertensive Heart Disease. In Cardiac Hypertrophy and Failure. Ed. Swynghedaw B. Inserm/John Libbey Eurotext; 1990: Pags. 443-465.

  19. Senni M, Tribovilloy CM, Rodeheffer RJ, Jalobsen SJ, Evans JM, Bailey KR, Redfield HM: Congestive Heart Failure in the Community. A Study in all Incident Cases in Olmsted County, Minnesota, in 1991. Circulation 1998; 98: 2282-2289.

  20. Raukin S, Lucke EJ, Gaynor W, Harpole DH, Feneley MP, Nikolic S, Maier GW, Tyson GS, Olsen CO, Glower DD: An Energetic Analysis of Myocardial Performance» en Cardiac Mechanics and Function in the Normal and Diseased Heart. Eds. Hori M., Suga H., Baan J., Yellin E.L. Springer-Verlag. 1989, Pags. 165-188.

  21. S y S S.U, Brutsaert DL: Systolic Relaxation in the Intact Heart. Research in Cardiac Hypertrophy and Failure. Ed. Swynghedaw Inserm/John Libbery. Eurotext 1990; Pags. 353-365.

  22. Gaasch WH: Clinical Diagnosis and Management of Left Ventricular Diastolic Dysfunction en Cardiac Mechanics and Function in the Normal an Diseased Heart. Eds. Hori M., Suga H., Baan J., Yellin E.L. Springer-Verlag 1989; pags. 291-298.

  23. Guadalajara JF: ¿Existe la Insuficiencia Cardíaca Diastólica? Arch Inst Cardiol Mex 2003; 73: 291-300.

  24. Diamond G, Forrester JS, Hergis J, Parmley WW, Danzing R, Swan HJC: Diastolic Pressure-Volume Relationships in Canine Left Ventricle. Circ Res 1971; 29: 267-275.

  26. Berne RM, Levy MN: Cardiovascular Physiology. 8th ed. Mosby 2001.

  27. Elzinga G, Westerhof N: Matching between ventricle and arterial load. Circ Res 1991; 68: 1495-1502.

  28. Gaughan JP, Furukawa S, Jecranadam V, et al: Sodium/calcium exchange contributes to contraction and relaxation in failed human ventricular myocytes. Am J Physiol 1999; 277: H714.

  29. Katz AM: Physiology of the heart, 2nd ed. Raven 1992.

  30. Francis GS, Gassler JP, Sonneblick EH: Pathophysiology and Diagnosis of Heart Failure, en Hurst’s The Heart. 10th Ed. McGraw Hill 2001.

  31. Lakatta EG: Length modulation of muscle performance : Franks Starling law of the heart. In the heart and cardiovascular system, 2 ed. Raven 1992.

  32. Francis GS: Pathophysiology of the Heart Failure Clinical Syndrome. In Textbook of Cardiovascular Medicine. 2 Ed. Lippincott Williams & Wilkins 2002.

  33. Galderisi M: Diastolic dysfunction and diastolic heart failure: diagnostic, prognostic and therapeutic aspects. Cardiovascular Ultrasound 2005; 3: 9.

  34. Gillebert TC, Leite-Moreira AF, De Hert SG: The hemodynamic manifestations of normal myocardial relaxation. A framework from experimental and clinical evaluation. Acta Cardiol 1997; 52: 223-230.

  35. Nishimura RA, Tajik J: Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician’s Rosetta Stone. J Am Coll Cardiol 1997; 30: 8-14.

  36. Mureddu GF, de Simone G, Greco R, et al: Left ventricular filling in arterial hypertension. Influence of obesity and hemodynamic and structural confounders. Hypertension 1997; 29: 544-551.

  37. Ferrannini E, Buzzigoli G, Bonadonna R, et al: Insulina resistance in essential Hypertension. N Engl J Med 1987; 317: 350-357.

  38. Swinne CJ, Shapiro EP, Lima SD, Fleg JL: Age associated changes in left ventricular diastolic performance in normal subject. Am J Cardiol 1992; 69: 823-826.

  39. Stratton JR, Levy WC, Schwartz RS, Abrass IB, Cerqueira M: Beta-adrenergic effects on left ventricular filling: influence of aging and exercises training. J. Appl Physiol 1996; 77: 2522-2529.

  41. Sarnoff SJ, Mitchell JH, Gilmore JP, Remensnyder JP: Homeometric autoregulation of the heart. Circ Res 1960; 8: 1077-1091.

  42. Cohn JN: Vasodilator therapy for heart failure: the influence of impedance on left ventricular performance. Circulation 1973; 48: 5-8.

  43. Cohn JN, Archibald DG, Ziesche S: Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration Cooperative Study. N Engl J Med 1986; 314: 1547-1552.

  44. Hirsh AT, Dzau , Creager MA: Baroreceptor function in congestive heart failure: effect on neurohormonal activation and regional vascular resistance. Circulation 1987; 75(suppl IV): 36-48.

  45. Bristow MR, Ginsberg R, Minobe M: Decreased catecholamine sensitivity and beta-adrenergic receptor density in falling human hearts. N Engl J Med 1982; 307: 205-211.

  46. The CONSENSUS trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429-1435.

  47. Gilbert EM, Anderson JL, Deitchman D: Long term B-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind randomized study of bucindolol versus placebo. Am J Med 1990; 88: 223-229.

  48. ACC/AHA 2005 Guideline update for the diagnosis and management of chronic heart failure in the adult. J Am Coll Cardiol 2005; 46: 1-86.

  49. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001; 22: 1527-1560.

  50. Task Force AHF Guideline. Eur Heart J 2005; 26: 384-416.

  51. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: Diagnosis and Management. Can J Cardiol 2006; 22(1): 23-45.

  52. Executive Summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Cardiac Failure 2006; 12: 10-38.

  53. I Diretriz Latino-Americana para la avaliaçao e conduta na insuficiencia cardíaca descompenzada. Arq Bras Cardiol 2005; 85(suppl III): 1-48.




2020     |     www.medigraphic.com